SARS-CoV-2 Pseudoviral Particles, JN.1.13.1 Variant
|
Catalog Number:
SCV2-PsV-JN1.13.1
|
|
SARS-CoV-2 Pseudoviral Particles, replication-deficient MLV pseudotyped with the SARS-CoV-2 spike protein (the latest variant, JN.1.13.1). (Mobile users please click "View Full Site" for details)
|
Detailed Description
Keyword: coronavirus, SARS, SARS-Cov, SARS-COV-2, covid19, covid-19, SARS pseudovirus, sars-cov-2 pseudovirus, sars-cov-2 spike, MLV, ace2, Omicron, Omicron variant
|
SCV2-PsV-JN1.13.1
|
|
Name
|
SARS-CoV-2 Pseudoviral Particles, JN.1.13.1 Variant
|
|
Description
|
The SARS-CoV-2 Pseudoviral Particles are replication-deficient Maloneymurine leukemia virus (MLV or MuLV) pseudotyped with the SARS-CoV-2 spike protein carrying the Omircon JN.1.13.1 variant genotype (GISAID Accession # EPI_ISL_1870906).
MLV-based virus system is a better choice than HIV-based lentivirus system for making pseudoviral particles in regards of lab safety and product quality. Gag-Pol is the only component from MLV.
|
|
Applications
|
Our Pseudovirus Particles generate robust chemiluminescent signals in cell assays when coupled with our firefly luciferase assay kit (Catalog # CA-L165), useful for 1) screening potential inhibitors to block SARS-CoV-2 entry and viral protein; 2) measuring the activity of and screening for neutralizing antibody against SARS-CoV-2.
|
|
Size
|
5 ml, for one multi-well plate
|
|
Storage
|
-70oC. Shipped on dry ice.
|
|
Note
|
1. Amenable to HTS format (96-well, 384-well and 1536-well format).
2. HEK293-hACE2 stable cells are available seperately (Cat..# CL-hACE2-001, CL-hACE2-002)
|
|
For Downloading
|
==>> DATA SHEET ==>> SAFETY DATA SHEET
|
|
|
|